About Southern California Liver Centers
Clinical Trials at Southern California Liver Centers
During the past decade, Southern California Liver Centers conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on
average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Southern California Liver Centers" #1 sponsor was "Gilead Sciences" with 10 trials, followed by "Bausch Health Americas, Inc." with 2 trials
sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "CStone Pharmaceuticals" with 1 trials sponsored and "Conatus Pharmaceuticals Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Liver Centers"
#1 collaborator was "Pharmaceutical Research Associates" with 1 trials as a collaborator and "Pharmasset" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Southern California Liver Centers
According to Clinical.Site data, the most researched conditions in "Southern California Liver Centers" are
"Hepatitis C, Chronic" (4 trials), "Chronic Hepatitis C" (3 trials), "Hepatic Encephalopathy" (2 trials), "Liver Fibrosis Due to NASH" (2 trials) and "Chronic Genotype 1a or 1b HCV Infection" (1 trials). Many other conditions were trialed in "Southern California Liver Centers" in a lesser frequency.
Clinical Trials Intervention Types at Southern California Liver Centers
Most popular intervention types in "Southern California Liver Centers" are "Drug" (15 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ribavirin" (4 trials), "GS-5885" (2 trials), "GS-9451" (2 trials) and "JNJ-73763989" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Southern California Liver Centers
The vast majority of trials in "Southern California Liver Centers" are
19 trials for "All" genders.
Clinical Trials Status at Southern California Liver Centers
Currently, there are NaN active trials in "Southern California Liver Centers".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Southern California Liver Centers,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Southern California Liver Centers, 1 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".